CDH1 and melanoma: Thus, these results suggest that cellular senescence promotes the ectodomain shedding of E-cadherin; the resultant seCad contributes to senescence-induced cancer progression, and that seCad is a potential therapeutic/preventive target for malignant melanoma, as well as a biomarker for prognosis prediction.